Ticagrelor metabolite M5
CAS No. 1251765-07-7
Ticagrelor metabolite M5( AR-C133913XX | T437700 | Ticagrelor metabolite M5, )
Catalog No. M23421 CAS No. 1251765-07-7
Ticagrelor metabolite M5 is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 109 | In Stock |
|
| 5MG | 155 | In Stock |
|
| 10MG | 219 | In Stock |
|
| 25MG | 440 | In Stock |
|
| 50MG | 642 | In Stock |
|
| 100MG | 888 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTicagrelor metabolite M5
-
NoteResearch use only, not for human use.
-
Brief DescriptionTicagrelor metabolite M5 is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor.
-
DescriptionTicagrelor metabolite M5 is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor. Compared to Clopidogrel, Ticagrelor has faster and more consistent inhibition on ADP-receptors. Ticagrelor is used in the treatment of acute coronary syndromes (ACS).
-
In Vitro——
-
In Vivo——
-
SynonymsAR-C133913XX | T437700 | Ticagrelor metabolite M5,
-
PathwayNeuroscience
-
TargetP2 Receptor
-
RecptorP2Y12
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1251765-07-7
-
Formula Weight370.43
-
Molecular FormulaC14H22N6O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESCCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Teng R, Oliver S, Hayes MA, Butler K. Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects. Drug Metab Dispos. 2010 Sep;38(9):1514-21. doi: 10.1124/dmd.110.032250. Epub 2010 Jun 15. PubMed PMID: 20551239.
molnova catalog
related products
-
Piperazine, 1-[(5-me...
Piperazine, 1-[(5-methyl-3-isoxazolyl)methyl]- (9CI) is a P2Y12 inhibitor.
-
RO3
RO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor.
-
Glycitein
Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
Cart
sales@molnova.com